STOCK TITAN

Akebia Therapeutics to Present at Piper Sandler Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Akebia Therapeutics, Inc. (Nasdaq: AKBA) announced that CEO John Butler will participate in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference on November 28th. The webcast will be available on Akebia's website for 90 days.
Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Nov. 20, 2023 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28th at 10:30 a.m. EST. 

The Piper Sandler Healthcare Conference will take place November 28 – November 30, 2023, in New York. 

A webcast of the fireside chat can be accessed through the "Investors" section of Akebia's website at https://ir.akebia.com for approximately 90 days following the conference. 

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
Mcarrasco@akebia.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-piper-sandler-healthcare-conference-301992889.html

SOURCE Akebia Therapeutics

FAQ

What is Akebia Therapeutics, Inc. participating in?

Akebia Therapeutics, Inc. is participating in the Piper Sandler 35th Annual Healthcare Conference where CEO John Butler will be part of a fireside chat.

When is the Piper Sandler Healthcare Conference taking place?

The Piper Sandler Healthcare Conference will be held from November 28th to November 30th, 2023, in New York.

How can the webcast of the fireside chat be accessed?

The webcast of the fireside chat can be accessed through the 'Investors' section of Akebia's website at https://ir.akebia.com for approximately 90 days following the conference.

Akebia Therapeutics, Inc.

NASDAQ:AKBA

AKBA Rankings

AKBA Latest News

AKBA Stock Data

272.47M
188.22M
2.47%
26.27%
6.4%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
CAMBRIDGE

About AKBA

akebia therapeutics, inc. is a biopharmaceutical company headquartered in cambridge, massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (hif) biology. akebia’s lead product candidate, vadadustat, is an investigational oral therapy in development for the treatment of anemia related to chronic kidney disease in both non-dialysis and dialysis patients. akebia’s global phase 3 program for vadadustat, which includes the pro2tect studies for non-dialysis patients with anemia associated with chronic kidney disease and the inno2vate studies for dialysis-dependent patients, is currently ongoing. for more information, please visit our website at www.akebia.com.